학술논문

Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection
Document Type
Article
Source
In: Molecular Therapy, Special issue on emerging diseases. (Molecular Therapy, 4 May 2022, 30(5):1885-1896)
Subject
Language
English
ISSN
15250024
15250016